The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes

Journal of Clinical Gastroenterology

Volumn 45, Issue 4, 2011, Pages 372-378

  Barritt IV, A Sidney ^a   Dellon, Evan S ^a   Kozlowski, Tomasz ^a   Gerber, David A ^a   Hayashi, Paul H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

diabetes; liver transplant; NAFLD; NASH; outcomes

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; GRAFT RECIPIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONALCOHOLIC FATTY LIVER; OBESITY; ORGAN DONOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

COMORBIDITY; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 79952795281     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181eeaff0     Document Type: Article

References (19)

1. Charlton M. Cirrhosis and liver failure in nonalcoholic fatty liver disease: molehill or mountain? Hepatology. 2008;47: 1431-1433. (Pubitemid 351702725)
2. Malik SM, deVera ME, Fontes P, et al. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant. 2009;9: 782-793.
3. Contos MJ, Cales W, Sterling RK, et al. Development of nonalcoholic fatty liver disease after orthotopic liver trans-plantation for cryptogenic cirrhosis. Liver Transpl. 2001;7: 363-373. (Pubitemid 32331542)
4. Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant. 2004;4:686-693. (Pubitemid 38637564)
5. Heneghan MA, Zolfino T, Muiesan P, et al. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis. Liver Transpl. 2003;9:921-928. (Pubitemid 37098840)
6. Charlton MR, Kondo M, Roberts SK, et al. Liver transplanta-tion for cryptogenic cirrhosis. Liver Transpl Surg. 1997;3: 359-364.
7. Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Trans-plantation. 2002;74:1007-1012. (Pubitemid 35191252)
8. Shields PL, Tang H, Neuberger JM, et al. Poor outcome in patients with diabetes mellitus undergoing liver transplanta-tion. Transplantation. 1999;68:530-535. (Pubitemid 29416629)
9. Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology. 2002;35:105-109. (Pubitemid 34032549)
10. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Character-istics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783-790. (Pubitemid 43345017)
11. Choi SY, Kim D, Kim HJ, et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol. 2009;104:1953-1960.
12. McKimmie RL, Daniel KR, Carr JJ, et al. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol. 2008;103:3029-3035.
13. Caldwell SH, Oelsner DH, Iezzoni JC, et al. Cryptogenic cirrhosis: clinical characterization and risk factors for under-lying disease. Hepatology. 1999;29:664-669. (Pubitemid 29109578)
14. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology. 2000;32:689-692.
15. Maheshwari A, Thuluvath PJ. Cryptogenic cirrhosis and NAFLD: are they related? Am J Gastroenterol. 2006;101:664-668. (Pubitemid 43340946)
16. John PR, Thuluvath PJ. Outcome of liver transplantation in patients with diabetes mellitus: a case-control study. Hepatology. 2001;34:889-895. (Pubitemid 33032023)
17. Montori VM, Basu A, Erwin PJ, et al. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care. 2002;25:583-592.
18. Hanouneh IA, Feldstein AE, McCullough AJ, et al. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl. 2008;14: 1287-1293.
19. Forman LM. Metabolic syndrome in liver transplantation: the elephant in the room. Liver Transpl. 2008;14:1245-1248.